Les maladies inflammatoires chroniques de l’intestin: que se passe-t-il quand le SARS-CoV-2 arrive? Résultats préliminaires du Centre Hospitalier Universitaire Hassan II de Fès, Maroc (à propos d’un cas)

SARS-CoV-2 infection is a major concern and a new threat to immunocompromised patients. Patients with chronic inflammatory bowel diseases (IBDs) are at increased risk of infections, in particular when they have active disease and are on immunosuppressive treatment. The purpose of this study was to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abid, Hakima, Atmani, Imane, Lahmidani, Nada, El Yousfi, Mounia, Benajah, Dafr-Allah, Ibrahimi, Sidi Adil, El Abkari, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325451/
https://www.ncbi.nlm.nih.gov/pubmed/34381526
http://dx.doi.org/10.11604/pamj.2021.38.382.27235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325451/
https://www.ncbi.nlm.nih.gov/pubmed/34381526
http://dx.doi.org/10.11604/pamj.2021.38.382.27235

Ejemplares similares